Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh
Afroza Akter,Tasnuva Ahmed,Imam Tauheed,Marjahan Akhtar,Sadia Isfat Ara Rahman,Fatema Khaton,Faisal Ahmmed,Jannatul Ferdous,Mokibul Hassan Afrad,Zannat Kawser,Mohabbat Hossain,Rabeya Khondaker,Mohammad Abul Hasnat,Mostafa Aziz Sumon,Asif Rashed,Shuvro Ghosh,Stephen B Calderwood,Richelle C Charles,Edward T Ryan,Purvesh Khatri,Holden Terry Maecker,Gerlinde Obermoser,Bali Pulendran,John D Clemens,Sayera Banu,Tahmina Shirin,Regina C LaRocque,Jason B Harris,Taufiqur Rahman Bhuiyan,Fahima Chowdhury,Firdausi Qadri
DOI: https://doi.org/10.1371/journal.pntd.0010102
2022-01-04
Abstract:Background: COVID-19 caused by SARS-CoV-2 ranges from asymptomatic to severe disease and can cause fatal and devastating outcome in many cases. In this study, we have compared the clinical, biochemical and immunological parameters across the different disease spectrum of COVID-19 in Bangladeshi patients. Methodology/principal findings: This longitudinal study was conducted in two COVID-19 hospitals and also around the community in Dhaka city in Bangladesh between November 2020 to March 2021. A total of 100 patients with COVID-19 infection were enrolled and classified into asymptomatic, mild, moderate and severe cases (n = 25/group). In addition, thirty age and sex matched healthy participants were enrolled and 21 were analyzed as controls based on exclusion criteria. After enrollment (study day1), follow-up visits were conducted on day 7, 14 and 28 for the cases. Older age, male gender and co-morbid conditions were the risk factors for severe COVID-19 disease. Those with moderate and severe cases of infection had low lymphocyte counts, high neutrophil counts along with a higher neutrophil-lymphocyte ratio (NLR) at enrollment; this decreased to normal range within 42 days after the onset of symptom. At enrollment, D-dimer, CRP and ferritin levels were elevated among moderate and severe cases. The mild, moderate, and severe cases were seropositive for IgG antibody by day 14 after enrollment. Moderate and severe cases showed significantly higher IgM and IgG levels of antibodies to SARS-CoV-2 compared to mild and asymptomatic cases. Conclusion/significance: We report on the clinical, biochemical, and hematological parameters associated with the different severity of COVID-19 infection. We also show different profile of antibody response against SARS-CoV-2 in relation to disease severity, especially in those with moderate and severe disease manifestations compared to the mild and asymptomatic infection.